Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term apoptosis-inducing ligand. Found 5 abstracts

Ralff MD, El-Deiry WS. TRAIL pathway targeting therapeutics. Expert Rev Precis Me. 2018 May;3(3):197-204.   PMCID: PMC6366666
Younes A, Vose JM, Zelenetz AD, Smith MR, Burris HA, Ansell SM, Klein J, Halpern W, Miceli R, Kumm E, Fox NL, Czuczman MS. A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. British Journal of Cancer. 2010 Dec;103(12):1783-7.   PMCID: PMCID: PMC3008610 [Available on 2011/12/7]
Leong S, Cohen RB, Gustafson DL, Langer CJ, Camidge DR, Padavic K, Gore L, Smith M, Chow LQ, von Mehren M, O'Bryant C, Hariharan S, Diab S, Fox NL, Miceli R, Eckhardt SG. Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study. Journal of Clinical Oncology. 2009 Sep;27(26):4413-21.   PMCID: not NIH funded
Bali P, Pranpat M, Swaby R, Fiskus W, Yamaguchi H, Balasis M, Rocha K, Wang HG, Richon V, Bhalla K. Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of Her-2. Clinical Cancer Research. 2005 Sep;11(17):6382-9.
Cohen SJ, Cohen RB, Meropol NJ. Targeting signal transduction pathways in colorectal cancer - More than skin deep. Journal of Clinical Oncology. 2005 Aug 10;23(23):5374-85.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term apoptosis-inducing ligand

Last updated on Wednesday, February 05, 2020